Concepts (155)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Anatomic Variation | 3 | 2019 | 20 | 0.97 | Why? |
| Infant, Newborn, Diseases | 2 | 2018 | 394 | 0.87 | Why? |
| Bicuspid | 1 | 2019 | 9 | 0.79 | Why? |
| Tooth Root | 1 | 2019 | 13 | 0.79 | Why? |
| Maxilla | 1 | 2019 | 70 | 0.74 | Why? |
| Anatomic Landmarks | 1 | 2018 | 44 | 0.73 | Why? |
| Silicone Elastomers | 1 | 2017 | 14 | 0.71 | Why? |
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2017 | 15 | 0.71 | Why? |
| Streptococcal Infections | 2 | 2018 | 255 | 0.69 | Why? |
| Neonatal Screening | 2 | 2017 | 285 | 0.69 | Why? |
| Mandible | 1 | 2018 | 72 | 0.69 | Why? |
| Neonatal Sepsis | 1 | 2018 | 69 | 0.68 | Why? |
| Contact Lenses, Hydrophilic | 1 | 2017 | 38 | 0.66 | Why? |
| Coloring Agents | 1 | 2017 | 116 | 0.64 | Why? |
| Cosmetics | 1 | 2017 | 100 | 0.62 | Why? |
| Whole Exome Sequencing | 1 | 2017 | 437 | 0.58 | Why? |
| Radiologists | 1 | 2021 | 873 | 0.56 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.54 | Why? |
| Radiography, Thoracic | 6 | 2021 | 5486 | 0.52 | Why? |
| Cone-Beam Computed Tomography | 3 | 2019 | 118 | 0.51 | Why? |
| Health Care Surveys | 1 | 2021 | 2942 | 0.44 | Why? |
| Early Diagnosis | 1 | 2018 | 2443 | 0.38 | Why? |
| Ultrasonography | 1 | 2021 | 4409 | 0.28 | Why? |
| Italy | 8 | 2021 | 38444 | 0.26 | Why? |
| Communicable Diseases | 1 | 2018 | 2148 | 0.25 | Why? |
| Hospital Mortality | 2 | 2021 | 22087 | 0.19 | Why? |
| Intensive Care Units, Neonatal | 2 | 2017 | 749 | 0.19 | Why? |
| Mandibular Nerve | 1 | 2018 | 7 | 0.18 | Why? |
| Tomography, X-Ray Computed | 4 | 2021 | 25144 | 0.18 | Why? |
| Diffusion | 1 | 2017 | 73 | 0.17 | Why? |
| Ethmoid Sinus | 1 | 2017 | 10 | 0.17 | Why? |
| Lymphoma, B-Cell, Marginal Zone | 1 | 2017 | 44 | 0.17 | Why? |
| Lung Neoplasms | 3 | 2020 | 3228 | 0.17 | Why? |
| Intestine, Small | 1 | 2020 | 336 | 0.17 | Why? |
| Practice Guidelines as Topic | 2 | 2021 | 15421 | 0.16 | Why? |
| Endothelium, Corneal | 1 | 2017 | 41 | 0.16 | Why? |
| Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 56 | 0.16 | Why? |
| Streptococcus agalactiae | 1 | 2017 | 194 | 0.16 | Why? |
| Radiology, Interventional | 1 | 2021 | 398 | 0.16 | Why? |
| Immunity, Maternally-Acquired | 1 | 2018 | 179 | 0.16 | Why? |
| Polystyrenes | 1 | 2017 | 98 | 0.16 | Why? |
| Infant, Newborn | 5 | 2018 | 23105 | 0.15 | Why? |
| Slit Lamp Microscopy | 1 | 2017 | 164 | 0.15 | Why? |
| Lipopolysaccharide Receptors | 1 | 2018 | 357 | 0.15 | Why? |
| Microspheres | 1 | 2017 | 261 | 0.15 | Why? |
| Arteries | 1 | 2017 | 283 | 0.14 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.14 | Why? |
| Incidental Findings | 1 | 2019 | 487 | 0.14 | Why? |
| Receptors, IgG | 1 | 2018 | 578 | 0.14 | Why? |
| TRPC Cation Channels | 1 | 2013 | 7 | 0.14 | Why? |
| Ion Transport | 1 | 2013 | 43 | 0.13 | Why? |
| Toll-Like Receptors | 1 | 2017 | 365 | 0.13 | Why? |
| Genome, Human | 1 | 2017 | 400 | 0.13 | Why? |
| Antibiotic Prophylaxis | 2 | 2017 | 399 | 0.13 | Why? |
| Radiology Department, Hospital | 1 | 2021 | 805 | 0.12 | Why? |
| Imaging, Three-Dimensional | 1 | 2018 | 680 | 0.12 | Why? |
| Fibroblasts | 1 | 2017 | 839 | 0.12 | Why? |
| Staphylococcal Vaccines | 1 | 2011 | 13 | 0.12 | Why? |
| Radiopharmaceuticals | 1 | 2017 | 763 | 0.12 | Why? |
| Lung | 1 | 2021 | 31049 | 0.12 | Why? |
| Ischemia | 1 | 2020 | 901 | 0.12 | Why? |
| Sex Characteristics | 1 | 2020 | 1120 | 0.12 | Why? |
| Betacoronavirus | 3 | 2020 | 204454 | 0.11 | Why? |
| Retrospective Studies | 7 | 2021 | 105322 | 0.10 | Why? |
| Policy Making | 1 | 2017 | 829 | 0.10 | Why? |
| Male | 16 | 2021 | 367725 | 0.10 | Why? |
| Age Distribution | 1 | 2020 | 3567 | 0.10 | Why? |
| Fluorodeoxyglucose F18 | 1 | 2017 | 1153 | 0.10 | Why? |
| Lactoferrin | 1 | 2011 | 208 | 0.10 | Why? |
| Cross Infection | 1 | 2011 | 8675 | 0.10 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2013 | 604 | 0.09 | Why? |
| Humans | 23 | 2021 | 930598 | 0.09 | Why? |
| Pneumonia, Viral | 4 | 2020 | 243684 | 0.09 | Why? |
| X-Rays | 2 | 2021 | 492 | 0.09 | Why? |
| Coronavirus Infections | 4 | 2020 | 253789 | 0.09 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2018 | 1573 | 0.09 | Why? |
| Calcium | 1 | 2013 | 708 | 0.09 | Why? |
| Positron Emission Tomography Computed Tomography | 1 | 2017 | 1458 | 0.09 | Why? |
| Stem Cells | 1 | 2013 | 595 | 0.08 | Why? |
| Peptide Fragments | 1 | 2018 | 2075 | 0.08 | Why? |
| Phenotype | 1 | 2018 | 4037 | 0.08 | Why? |
| Consensus | 1 | 2021 | 6345 | 0.08 | Why? |
| Adaptive Immunity | 1 | 2018 | 2585 | 0.08 | Why? |
| Endoscopy | 1 | 2017 | 1564 | 0.08 | Why? |
| Aged | 8 | 2020 | 215776 | 0.08 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.07 | Why? |
| Societies, Medical | 1 | 2021 | 6907 | 0.07 | Why? |
| Disease Progression | 2 | 2020 | 13580 | 0.07 | Why? |
| Middle Aged | 7 | 2021 | 270681 | 0.06 | Why? |
| Forecasting | 1 | 2018 | 4492 | 0.06 | Why? |
| Antineoplastic Agents | 1 | 2018 | 3550 | 0.06 | Why? |
| Infection Control | 1 | 2011 | 23131 | 0.06 | Why? |
| Severity of Illness Index | 2 | 2021 | 48226 | 0.06 | Why? |
| Female | 10 | 2020 | 380317 | 0.06 | Why? |
| Staphylococcal Infections | 1 | 2011 | 1099 | 0.06 | Why? |
| Adult | 8 | 2020 | 244371 | 0.05 | Why? |
| Antifungal Agents | 1 | 2011 | 1828 | 0.05 | Why? |
| Algorithms | 1 | 2018 | 7346 | 0.05 | Why? |
| Young Adult | 4 | 2020 | 93724 | 0.05 | Why? |
| Sensitivity and Specificity | 1 | 2021 | 22971 | 0.05 | Why? |
| Aged, 80 and over | 2 | 2020 | 88759 | 0.05 | Why? |
| Erlotinib Hydrochloride | 1 | 2018 | 48 | 0.05 | Why? |
| Heparin | 1 | 2011 | 2600 | 0.05 | Why? |
| Immunotherapy | 1 | 2011 | 2421 | 0.04 | Why? |
| Methyl-CpG-Binding Protein 2 | 1 | 2017 | 12 | 0.04 | Why? |
| Chemoradiotherapy | 1 | 2020 | 362 | 0.04 | Why? |
| Infant | 2 | 2017 | 30274 | 0.04 | Why? |
| Protein-Tyrosine Kinases | 1 | 2018 | 158 | 0.04 | Why? |
| Chromosome Deletion | 1 | 2017 | 62 | 0.04 | Why? |
| Chromosomes, Human, X | 1 | 2017 | 81 | 0.04 | Why? |
| Cell Count | 1 | 2017 | 228 | 0.04 | Why? |
| Tumor Burden | 1 | 2017 | 369 | 0.04 | Why? |
| Cytokines | 1 | 2018 | 15010 | 0.04 | Why? |
| Receptors, Interleukin-1 | 1 | 2017 | 161 | 0.04 | Why? |
| Dissection | 1 | 2017 | 164 | 0.04 | Why? |
| Neoplasm Metastasis | 1 | 2018 | 682 | 0.04 | Why? |
| Inositol 1,4,5-Trisphosphate | 1 | 2013 | 7 | 0.03 | Why? |
| Flufenamic Acid | 1 | 2013 | 6 | 0.03 | Why? |
| Disease-Free Survival | 1 | 2018 | 1654 | 0.03 | Why? |
| Pandemics | 5 | 2021 | 389249 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Antineoplastic Agents, Immunological | 1 | 2020 | 830 | 0.03 | Why? |
| Neoplasm Staging | 1 | 2020 | 1999 | 0.03 | Why? |
| Cadaver | 1 | 2017 | 626 | 0.03 | Why? |
| Reference Standards | 1 | 2017 | 1163 | 0.03 | Why? |
| Neovascularization, Physiologic | 1 | 2013 | 160 | 0.03 | Why? |
| Disease Outbreaks | 1 | 2020 | 27595 | 0.03 | Why? |
| Pregnancy Complications, Infectious | 1 | 2017 | 11559 | 0.03 | Why? |
| Primary Prevention | 1 | 2017 | 778 | 0.03 | Why? |
| Fatal Outcome | 1 | 2020 | 3438 | 0.03 | Why? |
| RNA Interference | 1 | 2013 | 534 | 0.03 | Why? |
| Surveys and Questionnaires | 1 | 2017 | 43792 | 0.03 | Why? |
| Leukocytes | 1 | 2017 | 1046 | 0.02 | Why? |
| Fetal Blood | 1 | 2013 | 573 | 0.02 | Why? |
| Child | 1 | 2019 | 70012 | 0.02 | Why? |
| RNA, Small Interfering | 1 | 2013 | 817 | 0.02 | Why? |
| Signal Transduction | 2 | 2017 | 7207 | 0.02 | Why? |
| Adolescent | 1 | 2019 | 86841 | 0.02 | Why? |
| Prenatal Care | 1 | 2017 | 1314 | 0.02 | Why? |
| Health Surveys | 1 | 2017 | 2841 | 0.02 | Why? |
| Cell Proliferation | 1 | 2013 | 1973 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Liver | 1 | 2017 | 4007 | 0.02 | Why? |
| Pyrazoles | 1 | 2013 | 1791 | 0.02 | Why? |
| Endothelial Cells | 1 | 2013 | 2048 | 0.02 | Why? |
| Cells, Cultured | 1 | 2013 | 5835 | 0.01 | Why? |
| Antibodies, Monoclonal | 1 | 2020 | 8041 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Mass Screening | 1 | 2017 | 8005 | 0.01 | Why? |
| Emergency Service, Hospital | 1 | 2020 | 14232 | 0.01 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.01 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.01 | Why? |
| Prognosis | 1 | 2018 | 32490 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2013 | 6153 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
Borghesi's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(155)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(71)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_